92 related articles for article (PubMed ID: 299242)
1. [Clinical significance of cholesterol excretion in the urine].
Jüngst D; Osterholzer M; Lazik E; Karl HJ
Acta Med Austriaca Suppl; 1979; 6():406-9. PubMed ID: 299242
[TBL] [Abstract][Full Text] [Related]
2. Is urinary cholesterol determination a possible screening test for urological carcinomas?
Jüngst D; Tauber R; Osterholzer M; Karl HJ
Urol Res; 1981; 9(1):1-3. PubMed ID: 7268998
[TBL] [Abstract][Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
4. [Cholesterol and urinary tract diseases].
Frick J; Spiteller G
Z Urol Nephrol; 1968 Dec; 61(12):833-8. PubMed ID: 4183283
[No Abstract] [Full Text] [Related]
5. Studies on the clinical significance of nonesterified and total cholesterol in urine.
Jüngst D; Wallner J; Pickel A; Stadler A; Eiermann W; Marx FJ; Karl HJ
Klin Wochenschr; 1981 Jun; 59(11):545-52. PubMed ID: 6167760
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
7. Urinary cholesterol in cancer screening.
Jüngst D; Osterholzer M; Tauber R; Karl HJ
Urology; 1982 Nov; 20(5):495-8. PubMed ID: 7147529
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
9. [Urine polyamine in patients with malignant urological diseases using a polyamine-test enzyme kit].
Sakai S; Koide T; Ito Y; Tei K; Deguchi T; Matsuda S; Kato N; Ban Y; Nishiura T
Hinyokika Kiyo; 1986 May; 32(5):661-5. PubMed ID: 3751793
[TBL] [Abstract][Full Text] [Related]
10. [Urinary excretion of cholesterol in various diseases. (Especially in cancer of the urogenital system)].
Spiteller-Friedmann M; Spiteller G; Spiteller H; Frick J
Osterr Z Erforsch Bekampf Krebskr; 1971; 26(1):25-35. PubMed ID: 5171242
[No Abstract] [Full Text] [Related]
11. [Excretion of urinary hydroxyproline in urinary tract diseases].
Guarino A; Comar OB; Taccone W; Cicalese V
Arch Sci Med (Torino); 1979; 136(2):249-54. PubMed ID: 92978
[TBL] [Abstract][Full Text] [Related]
12. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
[TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of serum tissue polypeptide antigen as a tumor marker for urogenital carcinomas--a comparison with other tumor markers in patients with renal cell carcinoma and prostatic carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Umehara T; Ohmura K
Hinyokika Kiyo; 1987 Oct; 33(10):1581-9. PubMed ID: 2451408
[TBL] [Abstract][Full Text] [Related]
14. Urinary cholesterol in follow-up of patients with urologic carcinomas or benign prostatic hyperplasia.
Jüngst D; Tauber R; Lazik E; Karl HJ
Urology; 1981 Jul; 18(1):65-7. PubMed ID: 6167049
[TBL] [Abstract][Full Text] [Related]
15. Haematuria investigation based on a standard protocol: emphasis on the diagnosis of urological malignancy.
Alishahi S; Byrne D; Goodman CM; Baxby K
J R Coll Surg Edinb; 2002 Feb; 47(1):422-7. PubMed ID: 11874263
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
[TBL] [Abstract][Full Text] [Related]
18. [Microscopic hematuria of postrenal origin].
Graber P
Schweiz Med Wochenschr; 1987 Dec; 117(50):1987-92. PubMed ID: 3433079
[TBL] [Abstract][Full Text] [Related]
19. Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma.
Yao WJ; Chang CJ; Chan SH; Chow NH; Cheng HL; Tzai TS; Lin SN
Anticancer Res; 1995; 15(6B):2819-23. PubMed ID: 8669871
[TBL] [Abstract][Full Text] [Related]
20. Prostatic tumors in Iran.
Habibi A; Manouchehri A; Diba MH; Sajadi M; Ghavam M
Int Surg; 1975 Aug; 60(8):405-7. PubMed ID: 1158617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
